Study identifies adhesion molecules key to cancer's spread through the body

October 9, 2012 by Anne Trafton
A microscopic image of cancer cells adhering to a spot coated with molecules found in the extracellular matrix. Credit: Nathan Reticker-Flynn

Although tumor metastasis causes about 90 percent of cancer deaths, the exact mechanism that allows cancer cells to spread from one part of the body to another is not well understood. One key question is how tumor cells detach from the structural elements that normally hold tissues in place, then reattach themselves in a new site.

A new study from MIT cancer researchers reveals some of the cellular that are critical to this process. The findings, published Oct. 9 in Nature Communications, offer potential new cancer , says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, and leader of the research team.

"As become more metastatic, there can be a loss of adhesion to normal . Then, as they become more aggressive, they gain the ability to stick to, and grow on, molecules that are not normally found in healthy tissues but are found in sites of tumor metastases," says Bhatia, who is also a member of the David H. Koch Institute for Integrative at MIT. "If we can prevent them from growing at these new sites, we may be able to interfere with metastatic disease."

Lead author of the paper is Nathan Reticker-Flynn, a PhD student in Bhatia's lab. Other authors are former students David Braga Malta and Mary Xu, postdocs Monte Winslow and John Lamar, and research scientist Gregory Underhill. In addition, Richard Hynes, the D.K. Ludwig Professor of Biology and a member of the Koch Institute, and Tyler Jacks, director of the Koch Institute, are contributing authors on this study.

Losing and gaining adhesion

Cells inside the human body are usually tethered to a structural support system known as the , which also helps regulate . Proteins called integrins, located on cell surfaces, form the anchors that hold the cells in place. When cancer cells metastasize, these anchors let go.

In this study, the researchers compared the adhesion properties of four types of cancer cells, taken from mice genetically engineered to develop lung cancer: primary lung tumors that later metastasized, primary lung tumors that did not metastasize, metastatic tumors that migrated from the lungs to nearby lymph nodes, and metastatic tumors that travelled to more distant locations such as the liver.

Building on a system they first described in 2005, the scientists developed technology allowing them to expose each type of cell to about 800 different pairs of molecules found in the extracellular matrix. After depositing cells onto a microscope slide in tiny spots—each containing two different extracellular matrix proteins—the researchers could measure how well cells from each tumor type bound to the protein pairs.

The researchers were surprised to find that adhesion tendencies of metastatic cells from different primary tumors were much more similar to each other than to those of the primary tumor from which they originally came. One pair of extracellular matrix molecules that metastatic tumors stuck to especially well was fibronectin and galectin-3, both made of proteins that contain or bind to sugars.

Although metastatic tumor cells share adhesion traits, they may take different pathways to get there, Reticker-Flynn says. Some tumor cells alter the combination of integrins that they express, while others vary the types of sugars found on their surfaces. All of these changes can result in higher or lower affinities for certain molecules found in the extracellular matrix of different tissues.

In an analysis of human tumor samples, both primary and metastatic, the researchers saw similar patterns. Specifically, they found that the more aggressive the metastasis, the more galectin-3 was present.

Previous studies have suggested that tumors pave the way for metastasis by secreting molecules that promote the development of environments hospitable to new cancer growth. Accumulation of galectin-3 and other molecules that help tumor cells colonize new sites may be part of this process, the researchers say.

"There's a lot of evidence to suggest that a hospitable niche for the tumor cells is being established prior to the cells even arriving and establishing a home there," Reticker-Flynn says.

Preventing cancer spread

The findings offer potential new ways to block metastasis by focusing on a specific protein-protein or protein-sugar interaction, rather than a particular gene mutation, Reticker-Flynn says. "If those changes do confer a lot of metastatic potential, we can start thinking about how you target that interaction specifically," he says.

The researchers tested this approach by genetically knocking down the amount of an integrin found on the surface of cancer cells, which they had identified as interacting with fibronectin and galectin-3. In those mice, tumor spread was reduced. Other possible therapeutic approaches include blocking binding sites on fibronectin and galectin-3 with antibodies, so tumor cells can't latch onto them.

To help with efforts to develop such drugs, the research team is now trying to figure out the details of ' interactions with galectin-3 and is developing new candidate therapeutics aimed at inhibiting those interactions.

Explore further: Biologists pinpoint a genetic change that helps tumors move to other parts of the body

Related Stories

Recommended for you

Opinion: How dangerous is burnt toast?

January 23, 2017

A new campaign is warning people that burning some food, such as toast, is a potential cancer risk. Here, the evidence for this claim is explored by David Spiegelhalter, Professor of the Public Understanding of Risk at the ...

Pancreatic tumors rely on signals from surrounding cells

January 19, 2017

Just as an invasive weed might need nutrient-rich soil and water to grow, many cancers rely on the right surroundings in the body to thrive. A tumor's microenvironment—the nearby tissues, immune cells, blood vessels and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.